BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/14/2024 5:31:16 PM | Browse: 370 | Download: 1327
 |
Received |
|
2023-11-07 14:46 |
|
Peer-Review Started |
|
2023-11-07 14:48 |
|
First Decision by Editorial Office Director |
|
2023-12-27 01:34 |
|
Return for Revision |
|
2023-12-27 01:34 |
|
Revised |
|
2024-01-12 11:11 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-02-18 01:54 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-02-18 03:19 |
|
Articles in Press |
|
2024-02-18 03:19 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-03-06 01:09 |
|
Publish the Manuscript Online |
|
2024-03-14 17:31 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Cumulative effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease in China
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing-Feng Chen, Zhuo-Qing Wu, Hao-Shuang Liu, Su Yan, You-Xiang Wang, Miao Xing, Xiao-Qin Song and Su-Ying Ding |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
72101236 |
| China Postdoctoral Science Foundation |
2022M722900 |
| Collaborative Innovation Project of Zhengzhou City |
XTCX2023006 |
| Nursing Team Project of the First Affiliated Hospital of Zhengzhou University |
HLKY2023005 |
|
| Corresponding Author |
Su-Ying Ding, MD, Director, Director, Doctor, Doctor, Health Management Center, The First Affiliated Hospital of Zhengzhou University, No. 1 Longhu Middle Ring Road, Jinshui District, Zhengzhou 450052, Henan Province, China. fccdingsy@zzu.edu.cn |
| Key Words |
Metabolic dysfunction-associated fatty liver disease; High-normal alanine aminotransferase level; Cumulative effect; Cox proportional hazards regression; Cohort study |
| Core Tip |
Limited evidence exists regarding the association between persistently elevated high-normal alanine transaminase (ALT) levels and the risk of new-onset metabolic dysfunction-associated fatty liver disease (MAFLD). This cohort study analysed 3553 participants followed for four consecutive health examinations between 2017 and 2020 and measured the cumulative effects of excess high-normal ALT (ehALT). Among the participants, the incidence rate of MAFLD showed a linear increasing trend for the cumulative ehALT group. The hazard ratios of new-onset MAFLD were significantly increased in the third and fourth quartiles of the equally and unequally weighted cumulative effects of ehALT. Among Chinese adults, long-term high-normal ALT levels were related to a cumulative increased risk of new-onset MAFLD. |
| Publish Date |
2024-03-14 17:31 |
| Citation |
Chen JF, Wu ZQ, Liu HS, Yan S, Wang YX, Xing M, Song XQ, Ding SY. Cumulative effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease in China. World J Gastroenterol 2024; 30(10): 1346-1357 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i10/1346.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i10.1346 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
